Integrase Inhibitors and Weight Gain -- to Switch or Not to Switch?

Debate Style Speaker(s)

• 

  Roger Bedimo, MD

  Professor of Medicine
  VA North Texas Health Care System
  Dallas, Texas

  Disclosure: Gilead Sciences : Consultant (Status: Terminated --- 11/07/2019); Merck & Co : Advisor or Review Panel member (Status: Ongoing); ViiV Healthcare : Advisor or Review Panel member (Status: Ongoing), Research Grant or Support (Status: Ongoing)